DEPLOYDatabase

Company

AGADE srl

AGADE srl is an Italian exoskeleton startup and Politecnico di Milano spin-off, founded in 2018/2020, developing semi-active exoskeletons originally designed…

Founded
2020
HQ
Sesto San Giovanni (MI), Italy
Status
Private

CategoryExoskeletons

Overview

AGADE srl is an Italian exoskeleton startup and Politecnico di Milano spin-off, founded in 2018/2020, developing semi-active exoskeletons originally designed to assist people with muscular dystrophy. Products include the AGADE exoskeleton for industrial and medical use.

Reality check

Origin (company-claimed)

Spin-off of Politecnico di Milano.

Products (company-claimed)

Agadexo Shoulder and Lowback industrial exoskeletons for manual material handling.

Semi-active assist (company-claimed)

Sensors and AI trigger assistance when lifting; removable battery lasts 8+ hours.

Verified record

Verified deployments
None on file
Active incidents
None on file

Key facts

EIC grant (reported, unconfirmed)

EUR 8.3M EIC Accelerator grant in 2021.

Patents (reported, unconfirmed)

8 patent documents.

Partnership (reported, unconfirmed)

Tacterion, for force sensor integration.

Data & sources

Web sources

3

3 sources backing this record.View all →

AGADE srl on the deployment map

View the global map

AGADE srl has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

No verified deployments for AGADE srl on the DEPLOY record yet. Track AGADE srl to know the moment the first one is verified.

Current leadership (4)

Founders (2)

See all founders across the registry →

Safety record

No incidents on record for AGADE srl.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

AGADE srl in third-party press

Peer companies

Mentioned on (4)

Registry pages whose text names AGADE srl.